Mikusová, V <br/><br/>
Mitoxantrone in combination with a DNA-PK inhibitor: possible therapy of promyelocytic leukaemia resistant forms.  [electronic resource] 

 -  Folia biologica  2011 
 - 200-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0015-5500 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acid Anhydride Hydrolases<br/>Antineoplastic Agents--pharmacology<br/>Cell Cycle Proteins--genetics<br/>DNA Breaks, Double-Stranded<br/>DNA End-Joining Repair<br/>DNA Repair Enzymes--genetics<br/>DNA-Activated Protein Kinase--antagonists & inhibitors<br/>DNA-Binding Proteins--genetics<br/>Drug Resistance, Neoplasm<br/>Drug Synergism<br/>HL-60 Cells--drug effects<br/>Homologous Recombination<br/>Humans<br/>Leukemia, Promyelocytic, Acute--drug therapy<br/>Mitoxantrone--pharmacology<br/>Nuclear Proteins--genetics